Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05185115

Efficacy of Nasal Oxygen Therapy to Reduce Postoperative Complications in Ankle Trauma Surgery in At-risk Patients: a Randomized Pilot Study.

Efficacy of Nasal Oxygen Therapy to Reduce Postoperative Complications in Ankle Trauma Surgery in At-risk Patients: a Randomized Pilot Study

Status
Active Not Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Ankle fractures are one of the most common surgeries in the world. After this kind of surgery, complications can occur, related to the scar or an infection. These complications are more frequent in "high-risk" patients. Nasal oxygen therapy is currently used in order to reduce these complications. However, no study proved its efficiency yet. In a cohort of 200 patients, one group will receive oxygen therapy during hospitalization, while the other will not. Complication rates will be observed up to 6 months after the operation

Detailed description

Prospective, single-center, comparative and randomized study based on a cohort of 200 patients with an ankle fracture. The patients will be assigned to one of the following group: with or without oxygen therapy. Patients in the experimental group will receive the oxygen just before the operation, and during the hospitalization. The rest of the care is the same for the 2 groups. Comparison of complication rate, of quality of healing, rate of revision surgery, delay in bone healing, rate of pseudoarthrosis, and ankle pain will be done between the 2 groups during a postoperative period of 6 months. A cost-utility analysis will also be realized. In a subgroup of 40 patients, additional transcutaneous oxygen pressure measurements will be performed to compare the evolution of tissue oxygenation between the 2 groups.

Conditions

Interventions

TypeNameDescription
DRUGOxygenadministration of oxygen at a flow rate of 3 liters per minute, via nasal cannula throughout the hospitalization.
OTHERno oxygen therapyNo oxygen therapy during hospitalization

Timeline

Start date
2022-04-09
Primary completion
2026-10-01
Completion
2026-10-01
First posted
2022-01-11
Last updated
2026-01-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05185115. Inclusion in this directory is not an endorsement.